-
EP1745034
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1745034
| EP1745034 - VANILLOID RECEPTOR LIGANDS AND THEIR USE IN TREATMENTS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 25.01.2013 Database last updated on 28.05.2024 | Most recent event Tooltip | 25.01.2013 | Application deemed to be withdrawn | published on 27.02.2013 [2013/09] | Applicant(s) | For all designated states AMGEN INC. M/S 27-4-A, Amgen Inc., One Amgen Center Drive Thousand Oaks, CA 91320-1799 / US | [2007/04] | Inventor(s) | 01 /
BALAN, Chenera 4586 Via Rodeo Thousand Oaks, California 91320 / US | 02 /
CHEN, Ning 2342 Gillingham Circle Thousand Oaks, California 91362 / US | 03 /
DOHERTY, Elizabeth M. 1542 Campbell Avenue Thousand Oaks, California 91360 / US | 04 /
GORE, Vijay Keshav 4302 Via Encanto Thousand Oaks, California 91320 / US | 05 /
NORMAN, Mark H. 130 Venus Street Thousand Oaks, California 91360 / US | 06 /
WANG, Hui-Ling 822 Lynnmere Drive Thousand Oaks, California 91360 / US | [2007/04] | Representative(s) | Grünecker Patent- und Rechtsanwälte PartG mbB Leopoldstrasse 4 80802 München / DE | [N/P] |
| Former [2007/04] | Grünecker, Kinkeldey, Stockmair & Schwanhäusser Anwaltssozietät Maximilianstrasse 58 80538 München / DE | Application number, filing date | 05722957.7 | 11.02.2005 | [2007/04] | WO2005US04370 | Priority number, date | US20040543985P | 11.02.2004 Original published format: US 543985 P | [2007/04] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2005077938 | Date: | 25.08.2005 | Language: | EN | [2005/34] | Type: | A1 Application with search report | No.: | EP1745034 | Date: | 24.01.2007 | Language: | EN | The application published by WIPO in one of the EPO official languages on 25.08.2005 takes the place of the publication of the European patent application. | [2007/04] | Search report(s) | International search report - published on: | EP | 25.08.2005 | Classification | IPC: | C07D401/12, C07D417/12, C07D413/12, C07D403/12, C07D417/14, C07D401/14, C07D403/14, A61K31/44, A61K31/444 | [2007/04] | CPC: |
C07D401/12 (EP,US);
A61P1/00 (EP);
A61P1/02 (EP);
A61P1/04 (EP);
A61P1/12 (EP);
A61P11/06 (EP);
A61P13/10 (EP);
A61P15/00 (EP);
A61P17/00 (EP);
A61P17/02 (EP);
A61P17/04 (EP);
A61P17/06 (EP);
A61P17/14 (EP);
A61P19/00 (EP);
A61P19/02 (EP);
A61P25/00 (EP);
A61P25/04 (EP);
A61P25/06 (EP);
A61P25/22 (EP);
A61P25/24 (EP);
A61P27/02 (EP);
A61P27/16 (EP);
A61P29/00 (EP);
A61P3/10 (EP);
A61P37/08 (EP);
A61P9/00 (EP);
C07D401/14 (EP,US);
C07D403/12 (EP,US);
C07D403/14 (EP,US);
C07D413/12 (EP,US);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2007/04] | Extension states | AL | 23.11.2006 | BA | 23.11.2006 | HR | 23.11.2006 | LV | 23.11.2006 | MK | 23.11.2006 | YU | 23.11.2006 | Title | German: | VANILLOIDREZEPTORLIGANDEN UND DEREN VERWENDUNG BEI BEHANDLUNGEN | [2007/04] | English: | VANILLOID RECEPTOR LIGANDS AND THEIR USE IN TREATMENTS | [2007/04] | French: | LIGANDS DU RECEPTEUR VANILLOIDE ET LEURS APPLICATIONS DANS DES TRAITEMENTS | [2007/04] | Entry into regional phase | 23.11.2006 | National basic fee paid | 23.11.2006 | Designation fee(s) paid | 23.11.2006 | Examination fee paid | Examination procedure | 05.12.2005 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 23.11.2006 | Examination requested [2007/04] | 16.03.2007 | Despatch of a communication from the examining division (Time limit: M04) | 25.07.2007 | Reply to a communication from the examining division | 01.09.2012 | Application deemed to be withdrawn, date of legal effect [2013/09] | 10.10.2012 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2013/09] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 16.03.2007 | Fees paid | Renewal fee | 23.11.2006 | Renewal fee patent year 03 | 13.02.2008 | Renewal fee patent year 04 | 13.02.2009 | Renewal fee patent year 05 | 16.02.2010 | Renewal fee patent year 06 | 15.02.2011 | Renewal fee patent year 07 | Penalty fee | Penalty fee Rule 85a EPC 1973 | 23.11.2006 | AT M01 Fee paid on 23.11.2006 | 23.11.2006 | BE M01 Fee paid on 23.11.2006 | 23.11.2006 | BG M01 Fee paid on 23.11.2006 | 23.11.2006 | CH M01 Fee paid on 23.11.2006 | 23.11.2006 | CY M01 Fee paid on 23.11.2006 | 23.11.2006 | CZ M01 Fee paid on 23.11.2006 | 23.11.2006 | DE M01 Fee paid on 23.11.2006 | 23.11.2006 | DK M01 Fee paid on 23.11.2006 | 23.11.2006 | EE M01 Fee paid on 23.11.2006 | 23.11.2006 | ES M01 Fee paid on 23.11.2006 | 23.11.2006 | FI M01 Fee paid on 23.11.2006 | 23.11.2006 | FR M01 Fee paid on 23.11.2006 | 23.11.2006 | GB M01 Fee paid on 23.11.2006 | 23.11.2006 | GR M01 Fee paid on 23.11.2006 | 23.11.2006 | HU M01 Fee paid on 23.11.2006 | 23.11.2006 | IE M01 Fee paid on 23.11.2006 | 23.11.2006 | IS M01 Fee paid on 23.11.2006 | 23.11.2006 | IT M01 Fee paid on 23.11.2006 | 23.11.2006 | LT M01 Fee paid on 23.11.2006 | 23.11.2006 | LU M01 Fee paid on 23.11.2006 | 23.11.2006 | MC M01 Fee paid on 23.11.2006 | 23.11.2006 | NL M01 Fee paid on 23.11.2006 | 23.11.2006 | PL M01 Fee paid on 23.11.2006 | 23.11.2006 | PT M01 Fee paid on 23.11.2006 | 23.11.2006 | RO M01 Fee paid on 23.11.2006 | 23.11.2006 | SE M01 Fee paid on 23.11.2006 | 23.11.2006 | SI M01 Fee paid on 23.11.2006 | 23.11.2006 | SK M01 Fee paid on 23.11.2006 | 23.11.2006 | TR M01 Fee paid on 23.11.2006 | Penalty fee Rule 85b EPC 1973 | 23.11.2006 | M01 Fee paid on 23.11.2006 | Additional fee for renewal fee | 29.02.2012 | 08 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]WO0062778 (BRISTOL MYERS SQUIBB CO [US]) [X] 1,2,4,7-9,12,13,15,16 * page 157; examples 454-457 *; | [X]WO0147921 (PHARMACOPEIA INC [US], et al) [X] 1,2,4,7-9,12,13,15-17 * page 53; example 157 *; | [X]WO0222602 (VERTEX PHARMA [US], et al) [X] 1,2,4,12,13,15,16 * compounds II-144-II-147,II-186-II-189,VIII-6,IX-81,IX-95,IX-96 *; | [X]WO0245652 (MERCK & CO INC [US], et al) [X] 1,2,4,7-9,12,13,15-17 * compounds 4-5,5-4,7-5,9-5,9-6,10-3,11-3,12-5,13-3,17-3,18-4,20-3,21-3,22-6,26-3,26-5,27-1,28-2,29-2,30-2,31-2,32-1,33-2,34-2,38-2,41-3,42-4,43-1,44-5,46-3,47-3,48-1,49-4,52-4,53-6,53-7,53-8,formula A *; | [X]WO0250065 (VERTEX PHARMA [US], et al) [X] 1,2,4,7-9,12,13,15,16 * compounds IIIa-14,IIIa-28,IIIa-30,IIIa-31 *; | [Y]WO03049702 (AMGEN INC [US], et al) [Y] 1-17 * the whole document *; | [X]WO03084953 (B & C BIOPHARM [KR], et al) [X] 1,2,4,7-9,12,13,15,16 * example - *; | [Y]WO03099284 (AMGEN INC [US], et al) [Y] 1-17 * the whole document *; | [X]WO2004000833 (VERTEX PHARMA [US], et al) [X] 1,2,4,7-9,12,13,15,16 * example I-54, page 33 *; | [X]WO2004000819 (ASTRAZENECA AB [SE], et al) [X] 1,2,4,7-9,12,13,15-17 * examples 36,39 *; | [X]US2004023977 (LARSEN ROBERT D [US], et al) [X] 1,2,4,7-9,15,16 * page 4, paragraph 0083 *; | [XP]WO2004014871 (AMGEN INC [US], et al) [XP] 1,3,4,12,13,15-17 * examples 203,209,210,213,219 *; | [AP]WO2004046133 (MERCK SHARP & DOHME [GB], et al) [AP] 1-17 * the whole document *; | [XP]WO2004089286 (IRM LLC [US], et al) [XP] 1,2,4,7-9,12,13,15-17 * examples 39,76 *; | [XP]WO2005007646 (NEUROGEN CORP [US], et al) [XP] 1,2,4,7-9,12,13,15-17 * page 54; example 1 *; | [E]WO2005013982 (VERTEX PHARMA [US], et al) [E] 1,2,4,7-9,12,13,15-17* example I-29; claim 37 * |